Lupin, Aurobindo units recall products in United States market

US-based units of drug firms Lupin and Aurobindo Pharma are recalling certain products in the American market, as per the latest enforcement report of the US Food and Drug Administration (USFDA). Baltimore-based Lupin Pharmaceuticals Inc, an arm of the Mumbai-based drug maker, is recalling 46,479 bottles of anti-viral medication Oseltamivir Phosphate for Oral Suspension.